BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32109249)

  • 1. miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma.
    Trilla-Fuertes L; Miranda N; Castellano D; López-Vacas R; Farfán Tello CA; de Velasco G; Villacampa F; López-Camacho E; Prado-Vázquez G; Zapater-Moros A; Espinosa E; Fresno Vara JÁ; Pinto Á; Gámez-Pozo A
    PLoS One; 2020; 15(2):e0229075. PubMed ID: 32109249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA expression profiling of Xp11 renal cell carcinoma.
    Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
    Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
    Nofech-Mozes R; Khella HW; Scorilas A; Youssef L; Krylov SN; Lianidou E; Sidiropoulos KG; Gabril M; Evans A; Yousef GM
    Cancer Med; 2016 Apr; 5(4):656-64. PubMed ID: 26860079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.
    Liep J; Kilic E; Meyer HA; Busch J; Jung K; Rabien A
    PLoS One; 2016; 11(6):e0157801. PubMed ID: 27336447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
    Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
    Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
    Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
    Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
    [No Abstract]   [Full Text] [Related]  

  • 7. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
    Saleeb R; Kim SS; Ding Q; Scorilas A; Lin S; Khella HW; Boulos C; Ibrahim G; Yousef GM
    Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic MicroRNAs Characterization in Clear Cell Renal Cell Carcinoma.
    Petrozza V; Carbone A; Bellissimo T; Porta N; Palleschi G; Pastore AL; Di Carlo A; Della Rocca C; Fazi F
    Int J Mol Sci; 2015 Dec; 16(12):29219-25. PubMed ID: 26670229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA profiling of human kidney cancer subtypes.
    Petillo D; Kort EJ; Anema J; Furge KA; Yang XJ; Teh BT
    Int J Oncol; 2009 Jul; 35(1):109-14. PubMed ID: 19513557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
    Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M
    J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.
    Khella HW; Bakhet M; Allo G; Jewett MA; Girgis AH; Latif A; Girgis H; Von Both I; Bjarnason GA; Yousef GM
    Carcinogenesis; 2013 Oct; 34(10):2231-9. PubMed ID: 23715501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.
    Heinemann FG; Tolkach Y; Deng M; Schmidt D; Perner S; Kristiansen G; Müller SC; Ellinger J
    Clin Epigenetics; 2018; 10():11. PubMed ID: 29410711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA profile in stage I clear cell renal cell carcinoma predicts progression to metastatic disease.
    Moynihan MJ; Sullivan TB; Burks E; Schober J; Calabrese M; Fredrick A; Kalantzakos T; Warrick J; Canes D; Raman JD; Rieger-Christ K
    Urol Oncol; 2020 Oct; 38(10):799.e11-799.e22. PubMed ID: 32534961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expression profiles predict clinical phenotypes and prognosis in chromophobe renal cell carcinoma.
    Ge YZ; Xin H; Lu TZ; Xu Z; Yu P; Zhao YC; Li MH; Zhao Y; Zhong B; Xu X; Zhou LH; Wu R; Xu LW; Wu JP; Li WC; Zhu JG; Jia RP
    Sci Rep; 2015 May; 5():10328. PubMed ID: 25981392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SATB1 is Down-regulated in Clear Cell Renal Cell Carcinoma and Correlates with miR-21-5p Overexpression and Poor Prognosis.
    Kowalczyk AE; Krazinski BE; Godlewski J; Grzegrzolka J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Dziegiel P; Kmiec Z
    Cancer Genomics Proteomics; 2016; 13(3):209-17. PubMed ID: 27107063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated microRNA-185 is associated with high vascular endothelial growth factor receptor 2 expression levels and high microvessel density in clear cell renal cell carcinoma.
    Yuan HX; Zhang JP; Kong WT; Liu YJ; Lin ZM; Wang WP; Guo JM
    Tumour Biol; 2014 Dec; 35(12):12757-63. PubMed ID: 25217984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma.
    Friedrich M; Heimer N; Stoehr C; Steven A; Wach S; Taubert H; Hartmann A; Seliger B
    Sci Rep; 2020 Apr; 10(1):6499. PubMed ID: 32300145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy.
    Saleeb RM; Plant P; Tawedrous E; Krizova A; Brimo F; Evans AJ; Wala SJ; Bartlett J; Ding Q; Boles D; Rotando F; Farag M; Yousef GM
    Eur Urol Focus; 2018 Sep; 4(5):740-748. PubMed ID: 28753789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p.
    Wotschofsky Z; Gummlich L; Liep J; Stephan C; Kilic E; Jung K; Billaud JN; Meyer HA
    PLoS One; 2016; 11(2):e0148746. PubMed ID: 26859141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.
    He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J
    PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.